Open AccessTravel associated probable case of SARS, Finland, with commentary from Health Canada
Author(s) -
Pekka Nuorti,
Pirkko Kotilainen,
Maija Lappalainen
Publication year - 2003
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.07.22.02234-en
Subject(s) - medicine , chest radiograph , mycoplasma pneumoniae , atypical pneumonia , pneumonia , chlamydia , mycoplasma pneumonia , etiology , respiratory system , levofloxacin , pediatrics , lung , immunology , antibiotics , microbiology and biotechnology , biology
A 24 year old, previously healthy Finnish man travelled to Toronto from 24-28 April 2003 to attend a large conference. After returning to Finland, he became ill with a high fever (40 °C) and mild cough on 30 April. The patient was admitted to Turku University Central Hospital and placed in isolation as a suspect case of severe acute respiratory syndrome (SARS). On admission, his chest radiograph was normal. On 2 May, a perihilar infiltrate was observed in his chest radiograph. A diagnosis of community acquired pneumonia was made and the case was reclassified as probable SARS. Fever lasted for five days and the patient did not require supplemental oxygen or mechanical ventilation. From 2-13 May, the patient received oral levofloxacin, which appeared not to influence the clinical course or laboratory parameters. There was no lymphopenia and the lactate dehydrogenase was normal. Nasopharyngeal samples for respiratory antigen detection (influenza A and B, adenovirus, parainfluenza 1,2,3 and respiratory syncytial virus) were negative. Chlamydia pneumoniae and Mycoplasma pneumoniae antibody testing did not indicate acute infection. Blood cultures were negative. No aetiology for the pneumonia was identified.